Loading…
Loading…
HBRM does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HBRM and 80,000+ other tickers.
See exactly how HBRM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HBRM and 80,000+ other tickers.
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea. The company also offers the AcnEase Skin Management System, intended to diminish acne marks and scars. Furthermore, Herborium provides non-prescription sexual health and performance…
Free Samples To Be Provided to Herborium Customers and Shareholders in 2021 Free Samples To Be Provided to Herborium Customers and Shareholders in 2021
Hires New French Market Manager Hires New French Market Manager
Revenues Expected to Commence in 4th Quarter of 2021. Revenues Expected to Commence in 4th Quarter of 2021.
The Company Reports no Dilution and 5th Consecutive Profitable Quarter in row. The Company Reports no Dilution and 5th Consecutive Profitable Quarter in row.
Houston, June 23, 2021 (GLOBE NEWSWIRE) -- Houston, Texas , June 23, 2021 Herborium Group, Inc. (OTC Pink: HBRM ), a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products (Botanical Therapeutics®) announced today that despite the COVID Pandemic and its impact on the economy, The company's performance remains strong and future activities and plans for new products and partnership are in a full swing. First Quarter sales for 2021 grew 19.7% while gross profit increases15.1% and gross margin grew from 61% to 64%. During this Quarter the company has also retired close to 1/5 of its debt ($500,000) to prepare the Company for upcoming partnership discussions.